Valuing a Healthcare Business for a Shareholder Exit

What does a shareholder exit valuation actually decide?

When a principal leaves a practice, the question is rarely what the whole business is worth. It is narrower: what is this parcel of shares or units worth, on the basis the owners agreed, at what date, and who pays for it. The first three answers come from a document rather than the accounts, so the work starts with the shareholder agreement, the constitution and any unitholder deed.

Enterprise value is the value of the business operations before taking account of how they are financed. Equity value is what the owners hold once borrowings, cash and items outside the trading business are dealt with. Most methods produce the first figure; a share price is the second divided among the shares on issue. Value and price differ too: value is a conclusion reached on a stated basis at a stated date, while price is what the parties agree. See share and equity valuations.

What triggers an exit, and why does the trigger matter?

Healthcare practices tend to have few owners, all of whom work in the business, so exits follow events in a person's life as often as commercial decisions: retirement, illness, death, a relationship breakdown, deadlock between principals, or a group buyer some owners want to accept.

Registration events matter here. Services Australia states that a health professional must first hold registration with the Australian Health Practitioner Regulation Agency (Ahpra) or an approved body to obtain a Medicare provider number. If a principal cannot practise, the earnings attached to them stop, so the exit and the earnings change arrive together.

Agreements attach different consequences to different triggers: a retiring principal may be paid on one basis, one leaving for a competitor on another, an estate on a third. Where the exit is contested, see shareholder and partnership dispute valuations.

What does the shareholder agreement decide?

Formula, market value or fair value

Agreements generally use one of three bases, and they are not interchangeable. A formula fixes the price mechanically, for example a stated proportion of the prior year's revenue. In healthcare it drifts abruptly rather than gradually, because a shift between bulk billed and privately billed patients, or a change in the mix between Medicare, National Disability Insurance Scheme and private funding, can move revenue and profit in opposite directions in one year.

Market value asks what the interest would fetch between hypothetical parties. Drawing on Spencer v Commonwealth of Australia [1907] HCA 82, the Australian Taxation Office describes the notional sale as one made after voluntary bargaining between a willing but not anxious seller and purchaser rather than a forced sale, with both parties fully informed.

Fair value is a defined term, not a synonym for market value, and its meaning comes from the document using it. Agreements often borrow the Corporations Act language for compulsory buy-outs: section 667C directs that fair value be found by valuing the company as a whole, allocating that value among the classes of issued securities, then allocating each class pro rata among its securities without a premium or a discount for particular securities.

Who is permitted to hold the shares

The clause has to work with the sector's ownership rules, because a transfer that cannot lawfully be performed helps nobody. The Pharmacy Council of New South Wales states that, with a few limited exceptions, you must be a registered pharmacist to hold a financial interest in a pharmacy, that the permitted holders are sole pharmacist operators, a partnership of registered pharmacists or a pharmacists' body corporate, and that it must be told about relevant changes to the business and to financial interests. A deceased pharmacist's shares cannot simply pass to a family member, which constrains both the clause and the field of buyers. See pharmacy valuations.

Appointment, instructions and deadlock

Most agreements name the appointing party or a nominating body, and a joint appointment produces one valuation binding both sides. Instructions do real work: the Australian Taxation Office says a market value is better supported where they preserve the valuer's independence, recognise the right to refuse an opinion where the information needed has not been provided, and establish that no fee depended on the outcome. The agreement should also set out what happens if the parties disagree, since without a mechanism they fall back on negotiation and then on remedies under the Corporations Act.

Which method applies, and how does a business value become a share price?

Choosing the method

Most healthcare practices are valued using the income approach, which the Australian Taxation Office describes as estimating market value from the income or cash flows an asset can be expected to generate in the future. That usually means capitalisation of future maintainable earnings: the representative annual profit the business can sustain from existing operations on arm's length terms, reached after normalisation removes owner-specific, one-off and non-commercial items, with a multiple then applied. The multiple is the inverse of the return a buyer requires, and rises as earnings become more durable and more transferable. See what is maintainable earnings.

Which earnings base is used matters more here than almost anywhere else. A base measured before interest and tax produces an enterprise value, so the bridge below applies. A base measured after financing costs is already an equity value, and deducting debt again would double count.

The largest normalisation is usually the principals' own remuneration. Many practices run a service entity arrangement, in which the entity holds the fit out, employs the reception and nursing staff and charges practitioners a service fee. The valuer works out what the business would earn if every working owner were engaged on terms an arm's length practitioner would accept, using the practice's own service agreements as the reference. A departing principal wants that adjustment modest; the continuing owners want it full. See payroll tax and contractor arrangements.

Other methods act as tests. Discounted cash flow projects future cash flows and discounts them to a present value at a rate reflecting their risk, which suits a practice with a genuine forecast. A net assets basis, identifiable assets less liabilities, is the floor where the practice earns little above the cost of the practitioners. Market evidence is a cross-check, since private healthcare transactions are rarely disclosed on comparable terms, though where fair value is fixed under the Corporations Act, consideration paid for securities in the same class in the previous six months must be taken into account. See valuation methods.

The bridge from enterprise value to equity value

Borrowings and cash. Bank debt, equipment finance on chairs, imaging, dispensing or rehabilitation equipment, and acquisition debt are deducted; cash is added.

Working capital. Stock and receivables less trade payables, at the level the business needs to operate: dispensary and retail stock in a pharmacy, clinical consumables, and receivables from Medicare, the National Disability Insurance Agency, the Department of Veterans' Affairs, private health funds and workers compensation schemes. Holdings above or below that level are a surplus or a shortfall.

Surplus and non-operating assets. Premises owned by the trading entity, a privately used vehicle or an investment portfolio are valued separately and added. Where the practice occupies premises held by an owner's family trust or superannuation fund, a market rent is substituted in the earnings: see premises and lease terms.

Shareholder loans, entitlements and liabilities that travel. Loans between the owners and the entity, and unpaid distributions, are settled separately and are not goodwill. Accrued annual and long service leave, make good obligations and any known payroll tax exposure are dealt with explicitly and only once: where the earnings already carry the annual cost, it is the accumulated balance that belongs here.

The equity value is then divided among the shares on issue, taking account of the classes and their rights.

Should a departing minority holder be paid a proportionate share?

A minority interest is a holding that cannot control the business: it cannot appoint directors, set remuneration, decide distributions or force a sale. A control premium is the extra amount an acquirer of control may pay for those rights; a minority discount is the corresponding reduction on a parcel without them. A clause pricing the exit as a proportion of the value of the company as a whole removes any discount by its terms, while a clause referring to the market value of the shares leaves the question open.

Two reference points help. Section 667C allocates value pro rata within a class without a premium or a discount. The Australian Securities and Investments Commission tells experts assessing a control transaction to compare values assuming full ownership of the target, saying it is inappropriate to discount because the shares acquired are a minority or portfolio parcel. Neither governs a private agreement, but both show that a proportionate allocation is recognised.

What valuation date applies, and why does timing change the answer?

The valuation date is the date at which value is assessed, and value is time specific. The Australian Taxation Office states that a valuation should be based on the most relevant and reliable information known, or reasonably foreseeable, at that date, and lists reliance on post valuation date information among the problems it commonly sees.

For an exit the date is usually when notice is given, a month or quarter end, the last balance date or completion, and each produces a different figure where clinical activity is seasonal.

The departure itself sits awkwardly across the date. If the resignation was known or reasonably foreseeable at the valuation date, its effect on maintainable earnings belongs in the assessment even though the accounts do not yet show it. Some agreements require the business to be valued as if notice had not been given, and the valuer applies that instruction and discloses it.

What happens to the departing practitioner's billings?

This is usually the largest single issue in a clinical exit. Goodwill is the value of the business above its identifiable net assets. Transferable, or commercial, goodwill attaches to the practice: location, brand, systems, the referral relationships the business holds and the patient records. Personal goodwill attaches to the individual and leaves with them.

Billings test which is which. Services Australia states that a health professional cannot use another health professional's provider number, and that a practitioner needs more than one Medicare provider number where they deliver health services in different locations. The items a departing practitioner has been claiming are theirs, and that revenue continues only if the patients stay and a replacement can be recruited to see them.

A valuation therefore examines what the departing principal personally generated, whether their patients or participants are attached to them or to the practice, whether referrers send work to the person or the address, whether a replacement is available in that discipline and location, and how long the position may sit vacant. Key person risk, the risk that value depends on one individual, is no footnote in a two principal practice. See practitioner dependence and transferable goodwill.

Restraint sits alongside this. It adds nothing of itself, but it protects the goodwill the remaining owners are paying for: where a departing practitioner may set up nearby and approach patients immediately, the continuing shareholders are buying a smaller and less certain stream of earnings. At the time of writing the Australian Government has announced a ban on non-compete clauses for low and middle income workers, described by the Treasury as conditions in employment agreements that prevent or restrict a worker from moving to a competitor, to take effect from 2027 following consultation and legislation. Whether it reaches a shareholder's restraint is a question for your lawyer.

How is the buy-out funded, and does that change the value?

Three routes are usual, each with approvals under the Corporations Act. The remaining shareholders may buy the shares personally, leaving the company's balance sheet alone. If they ask the company to help, section 260A permits financial assistance only where it does not materially prejudice the company, its shareholders or its ability to pay creditors, or where shareholders approve it, or an exemption applies.

The company may instead buy the shares back: section 257A allows a buy-back that does not materially prejudice the ability to pay creditors and follows the prescribed procedures. Because a buy-back from one shareholder is selective, section 257D requires prior approval either by a special resolution on which the departing shareholder and their associates cast no votes in favour, or by a resolution agreed to by all ordinary shareholders, with the notice of meeting and accompanying documents lodged with the Australian Securities and Investments Commission first. A selective capital reduction under section 256B instead has to be fair and reasonable to shareholders as a whole, not materially prejudicial to paying creditors, and approved by them.

The route also changes the tax position of the departing shareholder and of the company, since a buy-back is not treated the same way as a sale to the continuing owners, so the mechanism is worth settling with your accountant first.

Registration is the other constraint. The NDIS Quality and Safeguards Commission states that an NDIS registration is linked to a single Australian Business Number and is not transferable, and that registered providers must notify it of a change of ownership as soon as possible. For changes of ownership from 1 July 2026 it also states that a buyer of a provider delivering high risk or complex supports must start an audit no later than three months after the change, where that change significantly affects the organisation or its governance. A share transfer leaves the operating entity and its Australian Business Number intact, so registration is undisturbed, while moving the business to a new entity needs a fresh application. See NDIS business valuations.

None of this changes what the interest is worth. It changes what the parties can afford and how payment is structured, which is why deferred consideration, instalments and retention against a restraint or transition period are common. Where the price is deferred, the valuation and the payment terms are set out separately so any allowance for deferral is visible. See internal transaction valuations and succession planning valuations.

What does the report need to address so both sides can rely on it?

An exit valuation is read by two parties with opposite interests, so it must be capable of replication and challenge. The Australian Taxation Office says a valuation report should contain all necessary information to ensure a clear understanding of the analysis and demonstrate how the conclusions were reached, and that a market value is better supported where the report specifies the interest and associated rights valued. It expects the report to explain why the chosen methodology is most suitable, disclose any instructions that affected the process, declare independence and conflicts, and explain why a specific figure was adopted where the method gave a range.

The guidance the Australian Securities and Investments Commission gives experts translates to a private exit: use more than one methodology where possible and compare the values, say how much weight is placed on each, keep material assumptions specific rather than all embracing, and give a range as narrow as the evidence allows.

For a healthcare exit the report should also identify the earnings base and the normalisation applied, deal with the departing practitioner's contribution explicitly, set out the bridge from enterprise value to equity value line by line, state how the parcel was allocated its share, and record what was not verified. See valuation versus appraisal.

If you are working through an exit clause, or want to understand the number before notice is given, you can request a valuation or read more in transactions and shareholders.